Drug discovery for Duchenne muscular dystrophy via utrophin promoter activation screeningToxicology of frequently encountered nonsteroidal anti-inflammatory drugs in dogs and cats.Drug release from hydrazone-containing peptide amphiphiles.Flash pulmonary oedema: a rare but serious side effect of quinine sulphate.Discovery of nonsteroidal anti-inflammatory drug and anticancer drug enhancing reprogramming and induced pluripotent stem cell generation.A diclofenac suppository-nabumetone combination therapy for arthritic pain relief and a monitoring method for the diclofenac binding capacity of HSA site II in rheumatoid arthritis.UV-visible spectrophotometric simultaneous estimation of paracetamol and nabumetone by AUC method in combined tablet dosage formFirst-order derivative spectrophotometric estimation of nabumetone and paracetamol in tablet dosage form.Analytical power of LLE-HPLC-PDA-MS/MS in drug metabolism studies: identification of new nabumetone metabolites.Hypersensitivity to nabumetone: cross reactivity with naproxen.Characterization of polymer adsorption onto drug nanoparticles using depletion measurements and small-angle neutron scattering.Role of carbonyl reducing enzymes in the phase I biotransformation of the non-steroidal anti-inflammatory drug nabumetonein vitroDevelopment and validation of a stability-indicating RP-UPLC method for the quantitative analysis of nabumetone in tablet dosage formIn vitro characterization of the cytochrome P450 isoforms involved in the metabolism of 6-methoxy-2-napthylacetic acid, an active metabolite of the prodrug nabumetone[Determination of nabumetone and 6-methoxy-2-naphthylacetic acid in plasma using HPLC with UV and MS detection]Simultaneous determination of nabumetone and its principal metabolite in medicines and human urine by time-resolved fluorescenceEffects of nabumetone and dipyrone on experimentally induced gastric ulcers in ratsProgression of macular atrophy after PDT combined with the COX-2 inhibitor Nabumetone in the treatment of neovascular ARMDIdentification of combined conjugation of nabumetone phase I metabolites with glucuronic acid and glycine in minipig biotransformation using coupling high-performance liquid chromatography with electrospray ionization mass spectrometry
P921
Q28477551-657B1810-38AD-4386-A0AE-B376EE1D2E79Q34257984-EC4F7160-8F83-409B-9A15-D45B78834ED0Q35796515-97B8E453-F33E-4607-80EA-EEA14DEF12B9Q35863486-D6DE6049-640D-4C01-A81D-EFE2CA752B05Q36165721-3671D2BB-B1D5-4510-97D5-4241F97AEF87Q39236507-1E808433-C7A5-4061-98C2-1066D9199DD6Q40830412-1B8EB9EC-E5A2-44A0-A322-4629FFD73512Q40830931-945B2D3B-9EFE-4C64-A6D9-779460387DB2Q43691321-8A893B70-BE63-4CF5-867D-FE283A2E47B9Q44023704-1EDF0146-5344-4084-B072-6F1EA302D4F6Q45799156-45EA7253-1D1F-4B7B-AC6A-CFC2A1DAE10CQ61868138-8CB5B52E-35C9-4713-BA7A-5D23934183A8Q83384577-AD5FFD2A-78D8-4176-AE84-7E88282BB0BEQ84006393-82986239-0E8C-4781-A7F7-0E9E6CC5D11DQ84296096-EF9BB2A7-6D98-4E08-82AF-694A8A6BF15AQ84972779-603D1782-CB09-4EE9-9267-24434C31E95DQ85369135-98A0EFA8-DB0C-4459-A7F6-1A30747C6308Q85376639-8692EA65-E237-4212-B411-7DB9FA245E01Q86421871-FC829C2E-D8A5-400E-B6D0-71C394309B7F
P921
description
Arzneistoff
@de
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
Nabumeton
@de
Nabumeton
@pl
Nabumeton
@sh
Nabumeton
@sr
Nabumeton
@sv
Nabumetone
@nl
Nabumetonă
@ro
nabumeton
@nn
nabumetona
@ca
nabumetona
@es
type
label
Nabumeton
@de
Nabumeton
@pl
Nabumeton
@sh
Nabumeton
@sr
Nabumeton
@sv
Nabumetone
@nl
Nabumetonă
@ro
nabumeton
@nn
nabumetona
@ca
nabumetona
@es
altLabel
4-(6-Methoxy-2-naphthalenyl)-2-butanone
@cy
4-(6-Methoxy-2-naphthalenyl)-2-butanone
@en
4-(6-Methoxy-2-naphthyl)-2-butanone
@cy
4-(6-Methoxy-2-naphthyl)-2-butanone
@en
BRL-14777
@cy
BRL-14777
@en
Nabumeton
@en
Nabumetona
@en
Nabumetone
@en
Nabumetonum
@en
prefLabel
Nabumeton
@de
Nabumeton
@pl
Nabumeton
@sh
Nabumeton
@sr
Nabumeton
@sv
Nabumetone
@nl
Nabumetonă
@ro
nabumeton
@nn
nabumetona
@ca
nabumetona
@es